Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer

被引:0
作者
Valerie Cortez
Monica Mann
Seshidhar Tekmal
Takayoshi Suzuki
Naoki Miyata
Cristian Rodriguez-Aguayo
Gabriel Lopez-Berestein
Anil K Sood
Ratna K Vadlamudi
机构
[1] University of Texas Health Science Center,Department of Obstetrics and Gynecology
[2] University of Texas Health Science Center,Department of Cell and Structural Biology
[3] Kyoto Prefectural University of Medicine,Graduate School of Medical Science
[4] PRESTO,Graduate School of Pharmaceutical Sciences
[5] Japan Science and Technology Agency,Department of Gynecologic Oncology
[6] Nagoya City University,Center for RNA Interference and Non
[7] University of Texas MD Anderson Cancer Center,coding RNA
[8] University of Texas MD Anderson Cancer Center,Department of Cancer Biology
[9] University of Texas MD Anderson Cancer Center,Cancer Therapy and Research Center
[10] University of Texas Health Science Center,undefined
来源
Breast Cancer Research | / 14卷
关键词
Catalogue Number; Breast Cancer Progression; Therapy Resistance; Pargyline; Target Gene Promoter;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 331 条
[11]  
Lanz RB(2001)Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries Science 293 1150-1155
[12]  
O'Malley BW(2008)DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression Science 319 202-206
[13]  
Lonard DM(2008)Modulation of in situ estrogen synthesis by PELP1: potential ER autocrine signaling loop in breast cancer cells Mol Endocrinol 22 649-664
[14]  
Lanz RB(2007)Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR Nucl Recept Signal 5 e004-5512
[15]  
O'Malley BW(2007)Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor Cancer Res 67 5505-612
[16]  
Lydon JP(2009)The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype Breast Cancer Res Treat 120 603-444
[17]  
O'Malley BW(2010)PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-alpha target gene activation by regulating lysine demethylase 1 specificity EMBO Rep 11 438-385
[18]  
Vadlamudi RK(2010)Significance of ER-Src axis in hormonal therapy resistance Breast Cancer Res Treat 130 377-3176
[19]  
Manavathi B(2005)Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells Oncogene 24 3166-688
[20]  
Balasenthil S(2008)Preclinical modeling of endocrine response and resistance: focus on aromatase inhibitors Cancer 112 679-17537